HC Wainwright Forecasts Strong Price Appreciation for Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) Stock

Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) had its price objective upped by HC Wainwright from $8.00 to $21.00 in a report published on Tuesday,Benzinga reports. They currently have a buy rating on the stock.

Neuphoria Therapeutics Inc. – Common Stock Stock Performance

NEUP stock opened at $5.09 on Tuesday. Neuphoria Therapeutics Inc. – Common Stock has a fifty-two week low of $2.12 and a fifty-two week high of $16.08.

Neuphoria Therapeutics Inc. – Common Stock Company Profile

Neuphoria Therapeutics, Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.